ProAssurance (NYSE: PRA) merger cashes out executive equity at $25
Rhea-AI Filing Summary
Shook Kevin Merrick reported disposition transactions in this Form 4 filing.
PROASSURANCE CORP executive Kevin Merrick Shook, President of a subsidiary, reported that all of his equity in the company was cashed out in connection with the merger with The Doctors Company. On June 26, 2026, 53,237 shares of common stock were cancelled and converted into the right to receive $25.00 per share in cash.
On the same date, three awards of restricted stock units covering 11,778, 7,686 and 23,720 shares of common stock were also cancelled. Under the merger terms, these outstanding, unvested RSUs automatically vested and entitled him to a cash payment based on the $25.00 per share merger consideration. Following these transactions, the filing shows he no longer holds ProAssurance common stock or RSUs.
Positive
- None.
Negative
- None.
Insights
Executive equity was cashed out at a fixed merger price, not sold on the open market.
The transactions reflect a merger-driven cleanup of Kevin Merrick Shook’s ProAssurance equity, not discretionary trading. All common shares and unvested restricted stock units converted into cash at the agreed merger consideration of $25.00 per share.
Code D indicates dispositions to the issuer as part of the merger mechanics, consistent with the Agreement and Plan of Merger. With total holdings reduced to zero and no remaining derivatives in the filing, this looks like a standard cash-out when ProAssurance became a wholly owned subsidiary, rather than a market signal about the business.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Disposition | Restricted Stock Units | 23,720 | $0.00 | -- |
| Disposition | Restricted Stock Units | 7,686 | $0.00 | -- |
| Disposition | Restricted Stock Units | 11,778 | $0.00 | -- |
| Disposition | Common Stock | 53,237 | $25.00 | $1.33M |
Footnotes (1)
- On June 26, 2026, pursuant to that certain Agreement and Plan of Merger, dated as of March 19, 2025 (the "Merger Agreement"), among ProAssurance Corporation (the "Issuer"), The Doctors Company ("Parent") and Jackson Acquisition Corporation, a wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent. Reflects an adjustment to the number of shares beneficially owned after a reconciliation of the Issuer's records. At the effective time of the Merger (the "Effective Time"), upon the terms and subject to the conditions set forth in the Merger Agreement, each share of the Issuer's common stock, par value $0.01 per share (the "Common Stock") that was issued and outstanding immediately prior to the Effective Time (other than certain excluded shares) was cancelled and converted into the right to receive $25.00 per share in cash, without interest, and subject to any applicable withholding taxes (the "Merger Consideration"). Each restricted stock unit ("RSU") represents a contingent right to receive one share of Common Stock. Represents outstanding unvested RSUs (other than certain excluded RSUs, which were forfeited at the Effective Time in accordance with their terms). At the Effective Time, upon the terms and subject to the conditions set forth in the Merger Agreement, the outstanding, unvested time-based and performance-based RSUs (other than the excluded RSUs) automatically and immediately vested and were cancelled and entitled the holder to receive an amount in cash, without interest, equal to the product of (a) the total number of shares of Common Stock subject to the RSUs immediately prior to the Effective Time, multiplied by (b) the Merger Consideration.